Patents by Inventor Elazer Edelman

Elazer Edelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030192555
    Abstract: A method of producing a vascular lesion in an animal that resembles atherosclerosic lesions in humans. The method includes introducing cholesterol enriched with LDL or cholesterol enriched with LDL and monocytes, macrophages, leukocytes, smooth muscle cells or platelets into a proliferative lesion created by standard methods, to promote atherosclerosis.
    Type: Application
    Filed: May 5, 2003
    Publication date: October 16, 2003
    Inventors: Elazer Edelman, Campbell Rogers, Frederick G. Welt
  • Publication number: 20030093142
    Abstract: A stent device for minimizing deployment related injuries. The stent device includes at least one structural block of a desired length and includes a plurality of projection struts. The projection struts each have a defined shape, and form a foldable pattern so that the stent device folds onto itself. An expansion mechanism is stored within the structural block. The expansion mechanism unfolds the foldable patterns of the projection struts using expansion so that minimal damage occurs to a vessel wall.
    Type: Application
    Filed: October 16, 2002
    Publication date: May 15, 2003
    Inventors: Elazer Edelman, Kumaran Kolandaivelu
  • Patent number: 6492180
    Abstract: A method and apparatus for non-invasive extraction and/or detection of chemicals such as heavy metals, drugs such as cocaine and analytes such as blood glucose has been developed. A patch or hydrogel containing a reagent such as N-methyl pyrrole, or a similar compound, is used to extract the chemical or analyte to be measured through the skin or hair. This method is most useful for detecting analytes which are generally present in relatively constant blood concentrations. The method is particularly useful for the detection of heavy metals such as lead, lithium, copper, iron, and has been demonstrated to be useful with drugs such as cocaine and acetominaphen, and metabolic analytes like blood glucose. In the preferred embodiment, the method involves the use of the water miscible solvent N-methyl pyrrolidone (NMP) in an aqueous solution which is incorporated into an adsorbent pad or hydrogel.
    Type: Grant
    Filed: June 24, 1999
    Date of Patent: December 10, 2002
    Assignee: Transderm Technologies LLC
    Inventors: Larry R. Brown, Elazer Edelman, David Tseng
  • Publication number: 20020019055
    Abstract: A method and apparatus for non-invasive extraction and/or detection of chemicals such as heavy metals, drugs such as cocaine and analytes such as blood glucose has been developed. A patch or hydrogel containing a reagent such as N-methyl pyrrole, or a similar compound, is used to extract the chemical or analyte to be measured through the skin or hair. This method is most useful for detecting analytes which are generally present in relatively constant blood concentrations. The method is particularly useful for the detection of heavy metals such as lead, lithium, copper, iron, and has been demonstrated to be useful with drugs such as cocaine and acetominaphen, and metabolic analytes like blood glucose.
    Type: Application
    Filed: June 24, 1999
    Publication date: February 14, 2002
    Inventors: LARRY R. BROWN, ELAZER EDELMAN, DAVID TSENG
  • Publication number: 20010053928
    Abstract: A flow system device used for testing/creating fluid flow. The system comprises at least one fluid filled loop and a rotor stage for maintaining at least one rotor. The loop is positioned on the rotor. The device also includes a driving motor for rotating the rotor stage and a motion controller for controlling the speed and directional motion of the motor.
    Type: Application
    Filed: March 13, 2001
    Publication date: December 20, 2001
    Inventors: Elazer Edelman, Kumaran Kolandaivelu
  • Patent number: 5593974
    Abstract: Disclosed is a method for localized application of antisense oligonucleotides, which has been found to be effective in inhibiting expression and translation of a variety of genes. The method utilizes antisense oligonucleotides which are specific for the mRNA transcribed from the gene of interest. The antisense oligonucleotides are applied directly to the desired locus of the cells to be treated, where they hybridize with the mRNA and inhibit expression of the gene. Devices for localized antisense application and methods for making them also are described.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: January 14, 1997
    Assignee: Massachusetts Institute of Technology
    Inventors: Robert D. Rosenberg, Michael Simons, Elazer Edelman, Robert S. Langer, Jean-Luc DeKeyser